- Home
- VNDA vs PAL Comparison
VNDA vs PAL Comparison
Compare VNDA & PAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- PAL
- Stock Information
- Founded
- VNDA 2002
- PAL 2023
- Country
- VNDA United States
- PAL United States
- Employees
- VNDA N/A
- PAL N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- PAL
- Sector
- VNDA Health Care
- PAL
- Exchange
- VNDA Nasdaq
- PAL NYSE
- Market Cap
- VNDA 282.8M
- PAL N/A
- IPO Year
- VNDA 2006
- PAL 2024
- Fundamental
- Price
- VNDA $4.77
- PAL $9.89
- Analyst Decision
- VNDA Strong Buy
- PAL Strong Buy
- Analyst Count
- VNDA 2
- PAL 4
- Target Price
- VNDA $16.50
- PAL $16.00
- AVG Volume (30 Days)
- VNDA 652.5K
- PAL 237.0K
- Earning Date
- VNDA 05-07-2025
- PAL 05-14-2025
- Dividend Yield
- VNDA N/A
- PAL N/A
- EPS Growth
- VNDA N/A
- PAL N/A
- EPS
- VNDA N/A
- PAL N/A
- Revenue
- VNDA $198,772,000.00
- PAL $147,414,098.00
- Revenue This Year
- VNDA $14.36
- PAL N/A
- Revenue Next Year
- VNDA $44.53
- PAL $8.47
- P/E Ratio
- VNDA N/A
- PAL N/A
- Revenue Growth
- VNDA 3.18
- PAL N/A
- 52 Week Low
- VNDA $3.71
- PAL $7.24
- 52 Week High
- VNDA $6.75
- PAL $21.01
- Technical
- Relative Strength Index (RSI)
- VNDA 48.67
- PAL N/A
- Support Level
- VNDA $4.84
- PAL N/A
- Resistance Level
- VNDA $5.04
- PAL N/A
- Average True Range (ATR)
- VNDA 0.22
- PAL 0.00
- MACD
- VNDA -0.01
- PAL 0.00
- Stochastic Oscillator
- VNDA 26.32
- PAL 0.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.